Lili Yang

Shandong University — China

Medicine · Health Sciences

41h-index8.1kcitations161works12.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(69), Immune Cell Function and Interaction(55), T-cell and B-cell Immunology(30), Virus-based gene therapy research(24), Immunotherapy and Immune Responses(22)

Publications161 total

A proposal to simplify the definition of metabolic dysfunction-associated steatotic liver disease in youths
HepatoBiliary Surgery and Nutrition·2026Open Access
David Baltimore (1938–2025)
Nature Biotechnology·2025
Redefining multiple sclerosis with CAR-T cell therapy
Molecular Therapy·2025
Autologous, allogeneic, in vivo CAR for autoimmune diseases
Trends in Pharmacological Sciences·2025· 1 citedOpen Access
Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells
Proceedings of the National Academy of Sciences·2025Open Access
Innovative gene engineering strategies to address tumor antigen escape in cell therapy
Journal of Translational Medicine·2025· 4 citedOpen Access
Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity
Journal of Hematology & Oncology·2025· 5 citedOpen Access
Manufacturing synthetic viscoelastic antigen-presenting cells for immunotherapy
Nature Protocols·2025· 1 cited
Screening of selective serotonin reuptake inhibitors from Cyperus rotundus using immobilized neurotransmitter transporter affinity chromatography for antidepressant discovery
Analytical and Bioanalytical Chemistry·2025
54Allogeneic HSPC-engineered CD70-directed CAR-NKT cells for renal cell carcinoma targeting tumor, microenvironment, and alloreactive T cells
The Oncologist·2025· 1 citedOpen Access
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety
Molecular Therapy·2025· 4 citedOpen Access
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells
Cell Reports Medicine·2025· 7 citedOpen Access
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells
Med·2025· 15 citedOpen Access
A Nanovial-Based Platform for Functional Discovery of Antigen-Reactive TCRs from Unconventional T Cells
2025Open Access
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny
Nature Communications·2025· 1 citedOpen Access
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Cell·2025· 40 citedOpen Access
In vivo CAR engineering for immunotherapy
Nature reviews. Immunology·2025· 52 cited
Emerging trends in clinical allogeneic CAR cell therapy
Med·2025· 18 citedOpen Access
[Research progress of complement system activation involved in idiopathic pulmonary fibrosis].
PubMed·2025
Habitual Exercise Modulates Neuroimmune Interaction to Mitigate Aortic Stiffness
Circulation Research·2025· 1 cited
page 1 of 9Next →

Frequent Co-authors

Yan-Ruide Li(18), David Baltimore(16), Pin Wang(12), Yang Zhou(12), Zachary Spencer Dunn(9), Jiaji Yu(8), Yu-Chen Wang(7), Xi Wang(7), Donald B. Kohn(6), Owen N. Witte(6), Feiyang Ma(6), Matteo Pellegrini(6), Drake J. Smith(6), Yichen Zhu(6), Miao Li(6), Kuangyi Zhou(6), Dinesh S. Rao(5), Antoni Ribas(5), Zhe Li(5), Ying Fang(5)